Učitavanje...
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm
BACKGROUND: AVAGAST was an international, randomized, placebo-controlled phase III study of chemotherapy with or without bevacizumab as first-line therapy for patients with advanced gastric cancer. We performed exploratory analyses to evaluate regional differences observed in the trial. METHODS: Ana...
Spremljeno u:
| Izdano u: | Gastric Cancer |
|---|---|
| Glavni autori: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Japan
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906488/ https://ncbi.nlm.nih.gov/pubmed/29058097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-017-0773-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|